Somatic loss of BAP1 was due to different mutations in PlM of the right thoracic cavity, peritoneal mesothelioma, lung adenocarcinoma, and bladder cancer, whereas no BAP1 somatic mutation was observed in cholangiocarcinoma and PlM of the left thoracic cavity. This evidence concerns the gene BAP1 and cholangiocarcinoma.